Skip to main content
Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
4.640
+1.180 (34.10%)
At close: Dec 20, 2024, 4:00 PM
4.750
+0.110 (2.37%)
After-hours: Dec 20, 2024, 7:59 PM EST

Humacyte Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
185
Market Cap
597.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 20221.57M302.00K23.91%
Dec 31, 20211.26M-228.00K-15.29%
Dec 31, 20201.49M-4.70M-75.90%
Dec 31, 20196.19M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 1.13B
DocGo 694.97M
Sonida Senior Living 253.20M
Ginkgo Bioworks Holdings 217.95M
UroGen Pharma 89.36M
Zevra Therapeutics 24.49M
Verve Therapeutics 24.40M
MeiraGTx Holdings 13.93M
Revenue Rankings

HUMA News

More News